The superoxide-forming NADPH oxidase of human phagocytes is composed of membrane-bound and cytosolic proteins which, upon cell activation, assemble on the plasma membrane to form the active enzyme. Patients suffering from chronic granulomatous disease (CGD) are defective in one ofthe following components: p47-phox and p67-phox, residing in the cytosol of resting phagocytes, and gp9l-phox and p22-phox, constituting the membrane-bound cytochrome b55s. In an X-linked CGD patient we identified a novel missense mutation predicting an Asp --Gly substitution at residue 500 of gp9l-phox, associated with normal amounts of nonfunctional cytochrome b559 in the patient's neutrophils. In PMA-stimulated neutrophils and in a cell-free translocation assay with neutrophil membranes and cytosol, the association of the cytosolic proteins p47-phox and p67-phox with the membrane fraction of the patient was strongly disturbed. Furthermore, a synthetic peptide mimicking domain 491-504 of gp9l-phox inhibited NADPH oxidase activity in the cell-free assay (IC5o about 10 ,uM), and the translocation of p47-phox and p67-phox in the cell-free translocation assay. We conclude that residue 500 of gp9l-phox resides in a region critical for stable binding of p47-phox and p67-phox. (J. Clin. Invest. 1994.95:2120-2126